Protembis raised €8.6M in a Series A round in Oct 2018. The company is based in Aachen, Germany. Investors in the round: Abiomed Inc., coparion, Seed Fonds III. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
